Back HIV/AIDS HIV/AIDS Topics HIV Treatment

7. Simplified Dolutegravir Therapy Looks Promising

The potent HIV integrase inhibitor dolutegravir (Tivicay) taken with a single well-tolerated NRTI fully suppressed viral load in people starting antiretroviral therapy for the first time, while dolutegravir monotherapy was able to keep HIV suppressed in most treatment-experienced people who started with undetectable viral load, according to studies presented at the European AIDS Conference in October.

alt

Read more:

8. Long-term HIV Remission and Post-Treatment Control

A young woman who was infected with HIV at birth and received very early antiretroviral therapy (ART) as a baby has maintained a viral load below the limit of detectability of standard tests for more than 12 years after stopping treatment, shedding more light on "post-treatment control" as a potential functional cure strategy.

alt

Read more:

Happy Holidays from HIVandHepatitis.com

alt

San Francisco AIDS Foundation Opens Strut Health and Wellness Center2

TEXT

alt

Read more:

HIVandHepatitis.com 2015 Conference Coverage

Article listings by topic from all HIVandHepatitis.com conference coverage in 2015, including the Conference on Retroviruses and Opportunistic Infections (CROI), EASL International Liver Congress, International AIDS Society Conference in Vancouver, and AASLD Liver Meeting.

alt

Read more:

Happy New Year from HIVandHepatitis.com

alt

Trials Offer Evidence-based Blueprint for HIV Treatment and Prevention

A trio of major clinical trials -- SMART, START, and HPTN 052 -- provide definitive evidence supporting prompt antiretroviral treatment for all people diagnosed with HIV, both to improve their own health and to reduce the risk of transmission to others, according to a recent commentary published in the December 3 edition of the New England Journal of Medicine. Further, results from the IPERGAY study, published in the same issue, add to the growing body of evidence supporting pre-exposure prophylaxis (PrEP) for HIV prevention.

alt

Read more: